Evaluation of an Innovative Speech-enabled Translator in Emergency Settings

March 4, 2021 updated by: Antony Janakiram, University Hospital, Geneva
Survey-based satisfaction, performance and technical features evaluation of a speech-enabled fixed-phrase translation tool (BabelDR) in an emergency department.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

42

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Geneva, Switzerland, 1205
        • University Hospitals of Geneva (HUG)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

30 patients were recruited with an average age of M=38.2 (SD=16.49) of which 53.33% were males. The distribution between the different languages was the following: Spanish (11), Arabic (4), Farsi (7), Tigrinya (7) and Albanian (1).

Description

Inclusion Criteria:

  • As per inclusion criteria, patients were required to have no understanding of French, thus making a diagnostic interview by the doctors impossible.

Exclusion Criteria:

  • Exclusion criteria concerned patients who shared a common language with the doctor and/or were not able to read in their native language.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Satisfaction evaluation through a 4-point scale survey
Time Frame: During the consultation
Are patients' and doctors' satisfied with the use of BabelDr?
During the consultation
Efficacy evaluation through a 2-point scale survey
Time Frame: During the consultation
Can BabelDr be efficient tool in an emergency context: are doctors' able to reach a diagnostic with the tool?
During the consultation
Technical features evaluation through a 4-point scale survey
Time Frame: During the consultation
Are the technical features appreciated by the doctors'?
During the consultation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Geneva

Collaborators

University of Geneva, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

November 29, 2018

Primary Completion (ACTUAL)

January 20, 2020

Study Completion (ACTUAL)

January 20, 2020

Study Registration Dates

First Submitted

February 19, 2021

First Submitted That Met QC Criteria

March 4, 2021

First Posted (ACTUAL)

March 9, 2021

Study Record Updates

Last Update Posted (ACTUAL)

March 9, 2021

Last Update Submitted That Met QC Criteria

March 4, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Réq 2017-00996

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diagnoses Disease

Clinical Trials on the translation tool BabelDr

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe